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ABSTRACT  The activity of glycogen phosphorylase, an enzyme that is activated by both cAMP 
and  calcium,  was  used  as  an  indicator  of  the  state  of  the  cytoplasm  after  chemotactic 
stimulation of polymorphonuclear leukocytes (neutrophils). The activity of the enzyme showed 
a  clear  dependence  on  cytoplasmic  calcium.  Addition  of  the  calcium  ionophore  A23187 
caused  a 4-5-fold  increase  in  activity  of phosphorylase  a.  In the absence  of external  Ca  2+, 
A23187 caused  only brief transient activation of phosphorylase; probably reflecting release of 
sequestered intracellular Ca  2÷. Addition of the chemotactic  peptide N-formylnorleucylleucyl- 
phenylalanine  (FNLLP)  caused  a  transient  2-3-fold  activation  of  the  enzyme.  The  dose- 
dependence of activation  by FNLLP showed a peak at 10  -a M, near the Kd of the receptor for 
FNLLP. The phosphorylase activity  peaks by 90 s and then declines,  returning to basal levels 
by 20 min after stimulation  with  10  -a M  peptide and  by 60 min with  10  -7 M  peptide.  This 
finding suggests that the cells do not need to maintain elevated cytoplasmic calcium levels to 
exhibit  stimulated  locomotion.  Thus,  if  calcium  continues  to  modulate  the  motility,, there 
either  must  be  highly  localized  changes  that  are  not  detected  in  measures  of  the,, total 
cytoplasm,  or the sensitivity  to calcium  must be variable such  that basal levels are sufficient 
to maintain locomotion. Cells loaded with the fluorescence calcium  probe quin2 (0.6 mM) in 
the presence or absence of external Ca  2÷ had elevated  phosphorylase levels  before addition 
of  FNLLP. Thus,  the  presence  of quin2  may alter the cytoplasmic  Ca  2+ level,  and  it clearly 
alters  some aspects  of the neutrophil  physiology.  Phosphorylase  a appears to be a sensitive, 
nonperturbing indicator of the cytoplasmic calcium levels. 
Chemotactic  peptides  are  known  to  have  both  acute  and 
chronic  effects  on  polymorphonuclear leukocytes,  neutro- 
phils.  The acute effects include  cell ruffling,  adhesion,  and 
secretion of granule enzymes (34, 44).  These responses occur 
within seconds of peptide addition, reach peak levels in ~30 
s, and then decline toward baseline levels even in the contin- 
ued presence of peptide.  The chronic effects of the peptide 
include a stimulated rate of locomotion (chemokinesis), and 
a directional response to a gradient of peptide (chemotaxis) 
(27,  39,  40,  42,  43).  These responses continue for hours in 
the presence of peptide.  The sequence of molecular events 
that mediate the various responses is a topic of much current 
interest.  Early  molecular events include  a  rapid  change in 
phosphatidylinositol metabolism and increases in cytoplasmic 
Ca  2+ and cyclic AMP levels. These changes occur rapidly and 
reach their peak levels before receptor binding has reached its 
plateau. These responses then decline toward baseline levels. 
Whether there is a persistent small elevation of these or other 
mediators that regulate the motile responses over long time 
periods is unknown. 
If  the Ca  2÷ level continuously mediates the motile response 
stimulated by peptide, one might expect to find a persistent 
increase in the steady-state Ca  2÷ levels in cells in the presence 
of chemotactic factor. It is difficult to measure the activity of 
free cytoplasmic Ca  2÷. Neutrophils are too small for practical 
use  of intracellular  ion  electrodes.  45Ca2÷ labels whole-cell 
calcium, including bound sources, albeit with differing kinet- 
ics (25). The membrane-bound fluorescence probe chlortetra- 
cycline  has  been  used  to  observe the  chemotactic factor- 
induced depletion of a bound Ca  2÷ pool whose location is not 
well defined (24,  31).  The soluble fluorescence probe quin2 
has provided much useful information on cytoplasmic free 
Ca  2÷, but its use has several drawbacks, most importantly the 
chelating and buffering properties of the probe itself (4,  26, 
35).  There is evidence that the presence of quirt2 alters the 
actual  or  apparent  free  Ca  2÷  level,  and  that  it  stimulates 
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To study the long-term effects of the chemotactic peptides, 
we sought a  sensitive, quantitative, nonperturbing indicator 
of the state of the cytoplasm. We believe that the enzymatic 
activity of glycogen phosphorylase satisfies a number of these 
criteria: (a) The enzyme is endogenous, thus modifications of 
it  occur in  a  cell  undisturbed  by any buffering or foreign 
agents. Since the modification is covalent, the enzyme (and 
thus the state of the cytoplasm) can be assayed at any time by 
lysing the cells into medium in which the enzymatic activity 
is  stable.  (b) The enzyme is known to  have a  cytoplasmic 
location, thus it is susceptible to the same mediators as is the 
motile machinery of the cell.  (c) The enzymatic activity is 
positively regulated  by both  Ca  2÷  and  cAMP,  two  second 
messengers known to be altered by chemotactic peptides (1- 
3,  12-15,  18-20,  29,  32,  38).  The  phosphorylase  activity 
depends upon the enzyme itself being phosphorylated. Phos- 
phorylase  kinase  can  be  activated  by  a  cAMP-dependent 
kinase or by calcium binding directly to a  calmodulin-like 
subunit of the enzyme. As is described below, it appears that 
the  enzymatic regulation  in  leukocytes stimulated  by che- 
motactic peptide is sensitive to changes in Ca  2÷, and that the 
peptide-induced  changes  in  cAMP  do  not,  on  their  own, 
activate the enzyme. (d) The enzymatic activity can be quan- 
titated as a monitor of relative levels of cell activation (22). 
The total enzyme present can be assayed by including 5'AMP 
which activates the unactivated phosphorylase, phosphorylase 
b,  to  80%  of the  activity of the  phosphorylated  enzyme, 
phosphorylase a. 
We now report that:  (a) in  neutrophils as in hepatocytes 
the  activity  of the  enzyme  increased  in  response  to  the 
A23187,  in a  Ca2+-dependent manner; and (b)  the enzyme 
activity was rapidly increased by addition of the chemotactic 
peptide N-formylnodeucylleucylphenylalanine (FNLLP) ~ in 
a  manner  parallel  but  slightly  slower then  the  changes  in 
calcium measured by quin2 (25). (c) Removal of the peptide 
causes the enzymatic activity to rapidly return to basal levels. 
(d) These rapid changes were blocked by pertussis toxin which 
is known to block the quin2 response but not the cAMP rise 
(5,  15). The  best  (although  not  exclusive) explanation  for 
these  findings  is  that  changes  in  phosphorylase  a  activity 
reflect changes in cytoplasmic Ca  2+. 
We  have  used  this  enzyme to  monitor  the  steady-state 
activation of cells maintained in chemotactic peptides. The 
enzymatic activity is no higher in cells maintained in FNLLP 
than in control medium. Our findings suggest  that if Ca  2+ is 
involved in mediating the persistent motile functions of the 
neutrophil, this mediation must occur at basal calcium levels. 
MATERIALS AND  METHODS 
Media and Chemicals:  Hank's balanced salt solution with  10 mM 
HEPES buffer replacing bicarbonate, at pH 7.2 (Hank's-HEPES), was prepared 
from reagent grade chemicals. A23187 and FNLLP were obtained from Sigma 
Chemical Co. (St. Louis, MO). Quin2-AM and quin2 acid were obtained from 
Calbiochem-Behring Corp. (La Jolla, CA). [~4C]Glucose-  1  -phosphate (290 mCi/ 
mmol) was obtained  from Amersham-Seade.  Pertussis toxin  (islet-activating 
protein) was obtained from List Biochemical Laboratories Inc. (Campbell, CA). 
Dibutryl cAMP and 8-bromo-cAMP were obtained from Sigma Chemical Co. 
Cells  and  Treatments:  Rabbit  peritoneal  neutrophils  obtained  as 
described previously (41) were washed in saline and in Hank's-HEPES medium, 
~Abbreviation  used  in  this  paper:  FNLLP,  N-formylnorleucyl- 
leucylphenylalanine. 
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and  resuspended at 2 x  107  cells/ml  in Hank's-HEPES  medium  with 0.5% 
fatty acid-free  bovine serum albumin  (BSA; Sigma Chemical Co.). The cells 
were incubated  30 min with mild stirring at 37"C before the experiment  was 
initiated. For experiments with cells in Ca2÷-free medium, the Ca  2÷ in Hank's- 
HEPES was replaced with  1 mM EGTA. At each time point,  200 ul of cell 
suspension  was  pipetted  into  50  ul  sample  buffer  (250 mM  NaF/25  mM 
EGTA/25  mM EDTA/250  mM PIPES, pH 7.0) on ice. Samples were then 
assayed for phosphorylase a activity immediately or frozen at -20"C and later 
thawed for assay. 
For experiments using adherent cells, 1.5-ml aliquots of suspension at 5 x 
106 cells/ml were pipetted into 5-cm culture dishes. The cells settled 20-30 min 
at room temperature, then the surrounding medium was aspirated and replaced 
with 0.5 ml fresh Hank's-HEPES.  The dishes were moved to a 37"C room for 
the experiment. To maintain the cells in medium with a minimum of secreted 
products, the medium was replaced with fresh medium every 2 min throughout 
the experiment. For each time point, medium was aspirated from the dish, the 
dish was placed on ice, and 0.5 ml of ice-cold sample buffer diluted with saline 
was added (immediately). The dishes were scraped in the cold with a rubber 
policeman, and the samples were stored frozen for phosphorylase a assay. 
For quin2 studies, cells (107/ml) were incubated in either buffer A ( 150 mM 
NaCI, 5 mM KC1, 1.29 mM CaCI2, 1.2 mM MgCI2, 10 mM HEPES, pH 7.4) 
(20), or buffer  B (147 mM NaCI,  5  mM KC1, 1.9  mM  KH2PO4, 1.1  mM 
Na2HPO4, 5.5 mM glucose, 3 mM MgSO4, 1 mM MgCI2, pH 7.3; Sklar buffer), 
for 60 min at 37"C. Cells were then centrifuged, resuspended in either buffer A 
or buffer B (with 1.5 mM CaCI2 added), and equilibrated for 15 min at 37"C 
before peptide addition.  The quantity  of quin2 loaded in cells was determined 
by reading emission at 492 nm (excitation  339 nm) in the  presence of 0.2% 
Triton with or without 5 mM EGTA. Quin2 free acid was used as a standard. 
Cells (107/ml)  were loaded  with  pertussis  toxin  (200 ng/ml) in  Hank's 
HEPES without Ca  2+ or Mg  ÷2 and containing 0.1% BSA for 2 h at 37"C. They 
were spun, resuspended at 2 x  10  7 cells/ml in Hank's-HEPES with 0. 1% BSA. 
and equilibrated  for  15  min at  37"C. Peptide  was added  and samples were 
taken at various times for phosphorylase assay. 
Phosphorylase a Assay:  The activity of glycogen phosphorylase a 
was determined  by following [~4C]glucose-I-phosphate  incorporation  into gly- 
cogen, based on the  method  of Borregard and Herlin (8,  37). Samples were 
sonicated to break >90%  of the cells, then centrifuged in the cold to remove 
large particles. 30 ul of sonicate was added to 60 ~1 of assay buffer (15 mM 
[~4C]glucose-  l-phosphate [ 1 uCi/ml]/1.5%  rabbit liver glycogen/150 mM NaF/ 
100 mM PIPES, pH 6.4) and incubated at 30"C for 30-90  min depending on 
the  range  of activity  expected.  To  determine  the  [~4C]glucose-l-phosphate 
incorporation  into glycogen, 75 ul of each reaction mixture was spotted onto a 
Whatman No.  1 filter paper  circle (Whatman,  Inc., Clifton,  NJ)  and dried 
under a heat lamp. Unreacted substrate was washed out by soaking the filters 
in 66% ethanol, using at least 4 ml per sample, with four changes. The ~4C was 
counted  in a New England Nuclear (Boston, MA) Econofiuor in a Beckman 
scintillation  counter (Beckman  Instruments,  Inc.,  Palo  Alto, CA), with  an 
efficiency of 65%. 
RESULTS 
A23187 Raises Phosphorylase Activity 
The effect of A23187  on phosphorylase was examined by 
adding ionophore to a suspension of neutrophils in the pres- 
ence of 1.3 mM Ca  2÷ (Fig. 1). Addition of 2 x  10  -6 M A23187 
induced  a  rise  in  activity of phosphorylase that  reached a 
plateau after 10 min. The maximal activity reached was -4- 
5 times the basal level. A lower concentration of ionophore 
(2  x  10  -7 M) caused a much slower rise in enzyme activity, 
presumably due to a slower influx of Ca  2÷. With 1 mM EGTA 
present and no Ca  2+ in the external medium (Fig. 2), 5 x  10  -6 
M A23187 caused a slight transient increase in phosphorylase 
a  followed by return to the basal level.  Similar results were 
obtained in Ca2+-free medium without EGTA. 
Glycogen phosphorylase activity was  also  modulated  by 
cAMP.  The  presence  of millimolar  concentrations  of the 
cAMP analogues  8-Br-cAMP or dibutyryl cAMP activated 
glycogen phosphorylase. Both peptide and A23187 were able 
to stimulate the activity further. The peptide-induced response 
in the presence of 5 mM dibutyryl cAMP was similar in time 
course and  magnitude to that seen  in  control  cells.  In the 0
20
min
FIGURE 1
￿
Time course of calcium ionophore A23187 activation of
phosphorylase a. Neutrophils were resuspended at 1 .5 x 10' cells/
ml in medium containing 1.3 mM calcium. A23187 was added at
time zero, at 2 x 10-6 M (0), or at 2 x 10-' M (0). For all figures:
G-1-P, glucose-l-phosphate.
0
min
FIGURE 2 Activation of phosphorylase a by A23187 in the pres-
ence and absence of extracellular Cat+. The neutrophil suspension
at 2 x 10' cells/ml was preincubated 15 min at 37°C in medium
containing 1 .3 mM Ca' (0) or no calcium and 1 mM EGTA (0). 5
x 10-6 M A23187 was added at time zero.
presence of millimolar concentrations of 8-Br-CAMP, the
stimulation by low levels (5 x 10-$ M) ofA23187 was greater
than that seen in control cells (data not shown). This result
suggests that the calcium sensitivity of the kinase may be
increased by the cAMP analogues.
Transient Elevation of phosphorylase a by FNLLP
The addition of the chemotactic peptide FNLLP caused a
transient rise in phosphorylase a (Fig. 3). In the presence of
external Ca", the peak of activation was reached at 1-1 .5
min, with a return to nearly basal levels by 6 min. The
maximum amount of increase was typically 3-4-fold. In the
absence of external Ca", a rise in phosphorylase a activity
was still observed. The peak activity occurred earlier (0.5-1
min), and the overall levels ofactivity were lower. Thus, while
the enzyme did show a dependence upon extracellular Ca",
the chemotactic peptide did not require an external pool of
Cap* in order to raisethe levelofphosphorylase a. This finding
is consistent with the observation by others that chemotactic
factors release Ca" from an internal pool and increase the
permeability of the plasma membrane to Ca".
The FNLLP dose-dependenceofphosphorylase a activation
in the presence or absence of external Ca' is shown in Fig.
4. The range of peptide concentration between minimal and
maximal effect was 5 x 10-I°-10` M in the presence of
external Cal+ (Fig. 4A). The degree of activation was less at
10-' M than at l0-$ M. 10-' M peptide gave a response
similar to that at 10' M. A23187 (10-6 M) given as stimulus
min
FIGURE 3
￿
Time course of FNLLP activation of phosphorylase a in
medium containing 1 .3 mM Ca2* (!) or no calcium and 1 mM EGTA
(0y. Cell concentration was 3 x 10' cells/ml; the suspensions were
incubated 30 min at 37°C before 10' M peptide was added.
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FIGURE 4
￿
Dose-dependence of FNLLP activation of phosphoryl-
ase a in the presence (A) or absence (B) of external Ca". Conditions
were the same as for Fig. 3. Concentration of FNLLP was 5 x 10-'°
M (9); 1t?F9 M (0); 10-' M (A).
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Calcium Levels in Stimulated Neutrophils
￿
1193in the presence of external Ca  2+ activated phosphorylase to 
levels  higher than  any concentration of peptide,  thus  this 
finding indicates that the  peak  activity reached in  10  -8  M 
peptide is not a  result  of maximally stimulated enzyme. In 
the absence of external  calcium, the response continued to 
increase up to 10  -7 M peptide. 
Persistent Activation of Phosphorylase by FNLLP 
It is known that cell locomotion is stimulated for several 
hours in the presence  of FNLLP (43). Therefore, if calcium 
levels are involved in the stimulation of  locomotion, we would 
expect to find a difference  between the steady-state  levels of 
Ca  2÷ in cells incubated with or without FNLLP. We sought 
to test this hypothesis by comparing the steady-state  levels of 
phosphorylase  a  activity  in  the  presence  and  absence  of 
FNLLP. 
To improve the sensitivity  of these experiments,  the phos- 
phorylase a assay was adapted to cells plated on dishes.  The 
use of plated cells had several advantages over cells in suspen- 
sion.  Cell clumping, which occurs when peptide is added to 
cells in suspension,  was avoided. Furthermore, the medium 
surrounding the cells could be removed and replaced rapidly 
(within  5 s). By repeatedly changing the medium on the plated 
cells, we could keep the control cells in fresh medium free of 
activators that might be released  by the cells themselves  and 
the  peptide-treated  cells  in  fresh  peptide  free  of digestion 
products and other possible  activators.  The initial  transient 
increase  in  phosphorylase  activity  induced  by  FNLLP in 
plated cells was similar to that observed in cells in suspension 
(Fig. 6). 
Cells incubated in 2 x  10  -7 or 2 x  10  -s M FNLLP for 60 
min have phosphorylase activities  similar to that of control 
cells (Fig. 6). The return of the activity to baseline  depends 
on the peptide concentration. In 2 x  10  -8 M peptide, the level 
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FIGURE  5  Effect of intracellular quin2 on activation of phosphoryl- 
ase a  by  FNLLP.  Neutrophils suspended  at  107 per ml  in  Hank's- 
HEPES  medium  were  incubated  with  (O)  or  without  (O)  20  #M 
quin2-AM for 60 min at 37°C, then resuspended in medium without 
quin2.  The  intracellular content of quin2 acid was determined to 
be 0.6 mM, based on comparison of quin2 content in Triton-lysed 
cells with a standard sample of quin2 acid (29). The remaining cells 
were incubated with stirring at 37°C for 30 rain before addition of 
10  -7 M  FNLLP. 
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FIGURE  6  Time course of the log of phosphorylase activity of cells 
maintained in peptide. Cells were plated on petri dishes and incu- 
bated at 370C  for times up to 67  min  in  Hank's (+),  2  x  10  -8 M 
FNLLP (O),  or 2  x  10  -r M  FNLLP (0).  The medium on the dishes 
was  replaced  every  10  min.  At  various times the  phosphorylase 
activity of the cells was measured in sonicates of 10  -7 cells/ml. 
returns to baseline within 20 min, while in 2 x  10  -7 M peptide 
the activity remains above baseline  at 20 min but returns to 
baseline  by 60  min.  In  this  experiment,  the  medium  was 
exchanged every 10 min to ensure that neither peptide deg- 
radation nor depletion was contributing to the decline. Anal- 
ysis of protein on the dishes indicated that there was no cell 
loss during the prolonged incubations. Thus, there does not 
appear to be a permanent change in the levels of cytoplasmic 
calcium in cells maintained in peptide. 
It  is  known  that  neutrophils  respond  to  a  decrease  in 
concentration of chemotactic factor by ceasing to locomote 
and withdrawing their pseudopods (40). Removal of peptide 
must cause  some change in the state  of the cytoplasm. We 
investigated  whether  this  change  would  be  reflected  by  a 
change in phosphorylase a levels. Cells incubated for 20 or 60 
min in  medium containing peptide  were  switched  to fresh 
medium devoid of  peptide.  The phosphorylase a level of  these 
cells decreased  within  1.5  min.  The levels of phosphorylase 
observed in these cells sometimes went below that of cells in 
control medium. 
Pertussis Toxin Treatment Blocks Phosphorylase 
Activity Induced by FNLLP 
Treatment of neutrophils with pertussis toxin (islet-activat- 
ing protein) blocks the peptide-induced rise in Ca  ÷2 but not 
the cAMP rise (5, 15). We used treatment with pertussis toxin 
to evaluate the effect of the rise in cAMP on phosphorylase 
activity.  The activation of phosphorylase by 10  -8 M FNLLP 
was completely blocked in cells treated with 200 ng/ml per- 
tussis  toxin  for 2  h  (Fig. 7).  Basal  levels  of phosphorylase 
activity were not affected. Both A23187 (10 -6 M) and dibutryl 
cAMP (5 mM for 30 min at 37"C) could activate the phos- 
phorylase in pertussis toxin-treated cells to the same level as 
untreated cells. 
FNLLP Activation of Phosphorylase in Presence 
of Quin2 
It was of interest  to observe the peptide-induced activation 
of phosphorylase a in the cells loaded with quin2, a fluores- 
cence  probe  commonly used  as  an  indicator  of peptide- 
induced modulation of Ca  2÷  level  (20,  26,  38). Cells  were 
loaded with quin2 by incubation for 60 min in the presence "0 
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FIGURE  7  Peptide-induced  activa- 
tion of phosphorylase is blocked by 
treatment with pertussis toxin. Cells 
were  incubated  in  Hank's-Ca  +2- 
Mg  +2, with 0.1% BSA in the presence 
(O) or absence (0) of 200 ng/ml per- 
tussis  toxin  for  2  h  at  37°C.  They 
were spun,  resuspended  in  Hank's 
with Ca  +2 and Mg  +2, and equilibrated 
15  rain  at  37°C.  Peptide  (10  -a  M 
FNLLP) was added and samples were 
taken at the time points indicated. 
of 20 ~tM quin2-AM, resulting in intracellular accumulation 
of 0.6 mM quin2 acid. This concentration is typical of those 
used for measurement of intracellular free Ca  2÷. We found a 
substantial elevation of phosphorylase a in the quin2-1oaded 
cells as compared with the control (Fig. 5). Upon addition of 
10  -7 M FNLLP, little or no further activation of enzyme was 
observed.  The  quin2-1oaded  cells  could  release  lysosomal 
enzymes upon peptide treatment in the presence of 5 ttg/ml 
cytochalasin B, confirming that the cells can function when 
loaded with quin2. 
DISCUSSION 
We have used phosphorylase as a nonperturbing indicator of 
cytoplasmic activation by chemotactic peptide. We find that 
this enzyme which is activated by addition of peptide returns 
to  basal  levels in  the  continued  presence of peptide.  This 
suggests that the peptide-stimulated locomotion of  cells occurs 
when the mean cytoplasmic calcium levels are at basal levels. 
Usefulness of Phosphorylase Assay 
Since we were interested in investigating the small, long- 
term effects of peptide  on  cells,  we  needed  a  marker that 
would  not  itself perturb  the  cells  and  would  be  sensitive 
enough to detect small changes. We focused on changes in 
calcium levels since a  considerable amount of biochemical 
evidence suggests that calcium is a regulator of cell motility. 
However, there is no evidence that calcium levels are altered 
over the time course that peptide stimulates cell locomotion. 
Quin2 has been useful for many studies on calcium levels in 
neutrophils since it is a highly specific probe of cytoplasmic 
calcium. However, two properties of quin2 limited its useful- 
ness to us in this study. First, it does perturb the cell. It is a 
calcium buffer and can be used to lower cytoplasmic calcium 
levels.  It has also been shown to stimulate phosphatidylino- 
sitol metabolism in lymphocytes (16), and we report here that 
the presence of quin2 stimulates the phosphorylase activity. 
The second difficulty with quin2 is its inability to detect long- 
term small changes in levels of calcium. Although sensitive at 
physiological calcium concentrations, the baseline quin2 sig- 
nal often declines over a long time course making it difficult 
to detect small changes between treated and untreated cells. 
Glycogen phosphorylase is an endogenous enzyme whose 
activity  is  highly  regulated.  Both  calcium  and  cAMP  are 
known to positively modulate the enzyme activity; thus the 
enzyme has the  potential  to  be  sensitive to  both  of these 
second  messengers.  Furthermore,  since  the  regulation  in- 
volves phosphorylation of the enzyme, the level of activation 
can be measured at any time by lysing cells and assaying the 
enzyme activity in medium that prevents further modification 
of the  enzyme. As will  be discussed  below,  in  neutrophils 
stimulated  by  chemotactic  peptide  the  enzymatic  activity 
appears to be sensitive to changes in  Ca  +2  but not cAMP. 
However, because of the complexity of the regulation of the 
steady-state  activity  of glycogen  phosphorylase  (which  in- 
volves the activation of phosphorylase kinase and the activity 
of several phosphatases each of which may also be regulated), 
we cannot ascribe the changes in activity to a single factor. 
We propose that phosphorylase a is a useful indicator of the 
activation of the cytoplasm of neutrophil and that it is partic- 
ularly sensitive to calcium. 
Basis of Phosphorylase Activation 
The activity of the phosphorylase in neutrophils is clearly 
sensitive to changes in cytoplasmic calcium. The early phase 
of enzyme activation by A23187 in medium containing Ca  2+ 
(Fig.  l) has a nearly linear time course for either 2 ×  10  -7 M 
or 2 x  l0  -6 M ionophore. The initial slope shows roughly a 
10-fold  increase for the  10-fold increase in concentration of 
ionophore. This is consistent with a dependence of phospho- 
rylase a activation on the Ca  2÷ influx through pores created 
by the A23187. At the higher concentration (2 x  10  -6 M), the 
phosphorylase  activity  eventually  leveled  off at  a  plateau 
about 4-5 times the original basal level. This saturation point 
may represent the limit of available phosphorylase b substrate 
in  the  cell  or a  maximal steady-state between  kinase  and 
phosphatase activities. In the absence of external Ca  2÷, addi- 
tion  of A23187  resulted  in  a  brief transient  activation  of 
enzyme (Fig.  2). The result is probably due to the release of 
cellular bound Ca  2÷ into the cytoplasm and subsequent loss 
from the cell.  Our interpretation  is consistent with the  re- 
ported  ability of A23187  to deplete an  internal  Ca  2÷ pool 
required for lysosomal enzyme release (10). 
Activation of phosphorylase could also reflect changes in 
cAMP.  It is known that cAMP induces phosphorylation of 
the Ca2÷-dependent phosphorylase kinase; as a result of this 
phosphorylation the kinase is converted to a more active form 
(12).  We  find  that  analogues  of cAMP  do  stimulate  the 
phosphorylase activity in neutrophils. In one study, the kinase 
isolated  from  neutrophils  no  longer  required  calcium  for 
activity if  it was fully phosphorylated (33). However, we found 
that cells treated with concentrations of cAMP analogues that 
maximally  stimulated  the  phosphorylase  activity  still  re- 
sponded to peptide and to A23187.  In fact, the responses to 
low levels of A23187 were increased, suggesting an increased 
sensitivity of the kinase to calcium. An increased sensitivity 
of the phosphorylated kinase to calcium has been observed in 
muscle (11). 
The small transient elevation of cAMP known to occur 
during FNLLP stimulation (29) does not appear to activate 
the  phosphorylase.  We  have  shown  that  cells treated with 
pertussis toxin do not increase their phosphorylase activity 
upon the addition of peptide. Pertussis toxin does not block 
the peptide-induced rise in cAMP but does block the calcium 
rise as observed with quin2 (6,  16). The inability of peptide 
to activate the phosphorylase in the pertussis toxin confirms 
the conclusions of Borregard et at. that small cAMP increases 
are insufficient to cause covalent alterations of the phospho- 
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from cells undergoing phagocytosis. These cells show a small 
increase  in  cAMP  similar  to  that  caused  by  peptide.  The 
isolated kinase does not show the properties of the phospho- 
rylated  kinase  (9).  Therefore,  it  appears  unlikely  that  the 
activation  of phosphorylase  a  induced  by  phagocytosis or 
chemotactic peptides is mediated by cAMP. 
The level ofphosphorylase activity could also be modulated 
by the activity of the phosphatases. We have not investigated 
regulation of the phosphatases.  The rapid decrease in phos- 
phorylase  activity,  both  after  the  transient  rise  and  upon 
removal of peptide,  suggest that the phosphatases are active 
and that the steady-state level of the phosphorylase activity 
does reflect the current or at least recent kinase activity. 
There is a  report that the phosphorylase can be activated 
by 0.5 #g/ml phorbol myristate acetate, suggesting a  protein 
kinase C-dependent pathway of activation (9).  Whether this 
pathway  represents  a  direct  activation  of the  enzyme  or 
whether it represents an indirect effect due to increased leu- 
kotriene production or raised calcium levels (28) is not clear. 
Although phorbol myristate acetate at nanomolar levels does 
not raise cellular Ca  2+ as measured by quin2,  Sha'afi et al. 
have  shown  that  (1  #g/ml)  phorbol  myristate  acetate  does 
cause a quin2 response (17, 21, 23, 28). 
Thus, it appears that the phosphorylase a levels do reflect 
cytoplasmic calcium levels.  However, since the activity of this 
enzyme is  regulated  at  many  levels,  its  activity cannot  be 
ascribed uniquely to the calcium levels.  The phosphorylase a 
activity can be safely used as an indicator of an activation of 
the neutrophil cytoplasm for which calcium appears to be a 
primary modulator. 
Peptide Dose-dependence for Activation 
We  found that addition  of a  chemotactic peptide  caused 
transient  activation of phosphorylase in the presence or ab- 
sence of external Ca  2+ (Fig. 4).  The dose-dependence of this 
transient  phosphorylase a  activation  has  several  interesting 
features.  In  the  presence  of external  calcium,  the  enzyme 
activity peaked at -1  x  l0  -8 M  FNLLP and decreased at the 
higher concentration (10  -7 M). The quin2 signal has also been 
reported to be maximal after stimulation by peptide at con- 
centrations near the Kd of binding (20, 30). Thus, this level of 
stimulation by peptide may be sufficient to cause the maximal 
change in cytoplasmic calcium levels.  This concept proposed 
by Sklar  and  co-workers  is  supported  by the  fact  that  the 
quin2 signal reaches its peak level within  10-30 s of peptide 
addition.  This time point is well before receptor occupancy 
has plateaued  (30).  The phosphorylase activity peaks some- 
what later (60-90 s), possibly reflecting the time course of the 
kinase  activity after  the  calcium  is  raised.  However,  some 
cellular  responses  including  actin  polymerization  (36)  and 
phospholipase A2 activation (7) continue to increase as pep- 
tide  concentrations  are  raised  above  the  Kd.  Thus,  these 
responses must either be dependent  on features of receptor 
transduction separate from the cytoplasmic calcium levels or 
may depend on the duration as well as the magnitude of the 
raised calcium levels.  In the absence of calcium, phosphoryl- 
ase activity was not maximally stimulated by peptide  until 
the concentration was in excess of the Kd. The reason for the 
difference in the dose-response curve is not clear. 
1196  THE  JOURNAL  OF  CELL  BIOLOGY .  VOLUME  101,  1985 
Significance  of Results for Cell Locomotion 
We found that phosphorylase activity of cells maintained 
in peptide for 20-60 min returned to baseline. These findings 
suggest that cytoplasmic Ca  2+ returns to a  prestimulus level 
in the continued presence of FNLLP. Thus, if calcium con- 
tinues  to  modulate  motility,  there  must  either  be  highly 
localized changes that are not detected in the total cytoplasm 
or the cell's sensitivity to calcium must be variable such that 
basal Ca  2÷ levels are sufficient to maintain locomotion. It is 
possible that a decrease in cell Ca  2+ upon removal of peptide 
plays  a  role  in  the  negative  motile  response  (cessation  of 
locomotion and collapse of the lamellipodia)  which follows 
withdrawal of peptide from the medium of locomoting cells 
(40). 
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